Cognitive & Neuro

N-Acetyl Semax Amidate

Also known as NA-Semax Amidate · NA Semax · Semax amidate

AnecdotalIntranasalSubcutaneous injectionNot FDA-approved; sold largely as a research chemical; not separately approved as a drug; like base Semax, falls under FDA Category 2 bulk substance restrictions and is not covered by compounding enforcement discretion

N-Acetyl Semax Amidate is a structurally modified version of Semax that adds an acetyl group at the N-terminus and an amide group at the C-terminus. These modifications are reported to slow enzymatic degradation and to improve blood-brain barrier penetration, making the variant more resistant to proteolysis and longer-acting than unmodified Semax in preclinical descriptions. Its proposed mechanism mirrors Semax, centered on BDNF/NGF signaling and neurotransmitter modulation. Direct controlled studies of the amidate variant in humans are limited.

Studied / used for

used in nootropic protocols for cognition and focus support
described as sharing the neurotrophic mechanisms studied for Semax
explored for neuroprotection

Commonly reported side effects

nasal irritation with intranasal use
headache
changes in alertness or mild overstimulation
fatigue

Anecdotal. Limited formal evidence; reports are largely anecdotal. This reflects the strength of the research base, not effectiveness or a recommendation.

Not medical advice.

This is an educational reference. Peptalk does not recommend, prescribe, endorse, or rate any compound, and provides no dosing information. Do not start, stop, or change any peptide, hormone, supplement, or therapy based on this page. All clinical decisions must be made with your licensed healthcare provider.

← Back to all compounds